Cairn Surgical Reports Pivotal Trial Results for Its Breast Cancer Locator System
Cairn Surgical announced that its pivotal trial met its primary endpoint, indicating a lower positive margin rate and reduced reexcisions compared to the control group.
SEATTLE–(BUSINESS WIRE)– #BCSM–Cairn Surgical announced its pivotal trial met its primary endpoint, and reported a lower positive margin rate and reduced reexcisions versus control.